Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

Blood Trauma, Vascular Remodeling, and Vasoregulation with Total Body Continuous Versus Pulsatile Artificial Circulation

$6.77M USD

Funder NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
Recipient Organization Geisinger Clinic
Country United States
Start Date Aug 09, 2024
End Date May 30, 2029
Duration 1,755 days
Number of Grantees 1
Roles Principal Investigator
Data Source NIH (US)
Grant ID 10981322
Grant Description

Project Abstract Left ventricular assist device support is standard therapy for patients with advanced, life-threatening heart failure. However, current-generation impeller-based blood pumps have introduced a new “non-pulsatile” physiology with frequent adverse events. Lack of pulsatility contributes to blood trauma, endothelial and arterial remodeling, and

abnormalities in vasoregulation that predispose patients to bleeding, thrombosis, diastolic hypertension, and stroke. Cyclic speed modulation in which device impeller speed is rapidly increased/decreased has been developed to generate pulsatile blood flow. This emerging technology has potential to combine durability of

impeller-driven devices with physiologic benefits of pulsatility in order to reduce adverse events and improve quality of life for patients with artificial circulation devices. To date, no investigation has characterized (patho)physiologic effects of total-body pulsatile versus non-pulsatile blood flow with the same device. The

BiVACOR total artificial heart is a first-of-its-kind, impeller-based total artificial heart with the ability to generate continuous (non-pulsatile) or pulsatile blood flow through cyclic impeller speed modulation. In a chronic bovine model, we propose to investigate in vivo effects of non-pulsatile versus pulsatile flow with the BiVACOR on blood

trauma, arterial remodeling, and vasoregulation. We anticipate that compared to non-pulsatile support, pulsatile flow will 1) reduce blood trauma, 2) prevent pathologic changes in endothelial and arterial wall architecture and function, and 3) maintain normal vasoregulation during postural changes, transition to exercise, sleep, and other

activities of daily living. Data will provide insight into pathophysiologic mechanisms of adverse events in patients with impeller-based blood pumps. Findings will also be useful for the development of artificial pulsatility algorithms that mimic physiologic pulsatility in order to minimize blood trauma, prevent arterial remodeling, and

appropriately modulate vasomotor tone during daily activities.

All Grantees

Geisinger Clinic

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant